CD4 T cell deficiency or defective IFNc signaling render humans and mice highly susceptible to Mycobacterium tuberculosis (Mtb) infection. The prevailing model is that Th1 CD4 T cells produce IFNc to activate bactericidal effector mechanisms of infected macrophages. Here we test this model by directly interrogating the effector functions of Th1 CD4 T cells required to control Mtb in vivo. While Th1 CD4 T cells specific for the Mtb antigen ESAT-6 restrict in vivo Mtb growth, this inhibition is independent of IFNc or TNF and does not require the perforin or FAS effector pathways. Adoptive transfer of Th17 CD4 T cells specific for ESAT-6 partially inhibited Mtb growth while Th2 CD4 T cells were largely ineffective. These results imply a previously unrecognized IFNc/TNF independent pathway that efficiently controls Mtb and suggest that optimization of this alternative effector function may provide new therapeutic avenues to combat Mtb through vaccination. 
Introduction
IFNc is essential for defense against Mtb infection, as revealed by experimental studies using knockout mice and the unusually severe mycobacterial infections in patients with defects in the IFNc or IL-12 signaling pathways [1, 2, 3, 4] . The role of CD4 T cells in defense against Mtb infection has been inferred from the increased reactivation of latent Mtb infections in CD4 T cell deficient patients following HIV infection and severe tuberculosis observed in CD4 T cell-deficient mice [3, 5] . These clinical and experimental findings have led to a widely accepted model positing that the critical immunologic mechanism of anti-mycobacterial immunity involves CD4 T cells that secrete IFNc to activate bactericidal functions of Mtb-infected macrophages. Substantial evidence indicates that IFNc can activate murine macrophages to limit Mtb growth [6] [7] but the relative importance of this bactericidal mechanism and the cellular sources of IFNc are unknown. Evidence for an CD4 T cell dependent, IFNc independent mechanism of killing has been suggested by the finding that the frequency of Mtb-specific, IFNc-producing cells following immunization does not correlate with protection against infection and that depletion of CD4 cells exacerbates Mtb infection in mice despite the ongoing expression of IFNc [8, 9, 10, 11, 12] .
In this report, we have assessed the requirement of IFNc in protection by Mtb specific CD4 T cells. Using a model of adoptive transfer of Mtb specific effector CD4 T cells, we provide evidence for the surprising conclusion that IFNc is not a required mediator of CD4 T cell defense to Mtb. In support of this finding is our discovery that key mediators of IFNc-dependant immunity, inducible nitric oxide synthase and phagocyte oxidase, were not required for the early protective events mediated by adoptively transferred Th-1 skewed CD4 T cells. Although Th1-skewed cells were superior to Th2 or Th17-skewed cells in defense to Mtb, surprisingly, protection by Th1 -skewed cells was independent of the master regulator of Th1 differentiation, T-bet. Our results are contrary to a dominant role for IFNc production by effector CD4 in Mtb protection, but strongly support a requirement for Th1 mediated immunity to Mtb.
Results/Discussion

IFN-gamma and iNOS independent control of M. tuberculosis infection
To investigate the contribution of IFNc production by Mtbspecific CD4 T cells during infection, we compared the ability of WT and IFNc deficient, Mtb-specific CD4 T cells derived from the C7 TCR transgenic mouse [13] , to protect mice from infection. Naive C7 CD4 T cells, specific for the immunodominant Mtb antigen ESAT-6 in the context of the IA b MHC class II molecule, were activated in vitro under Th1-skewing conditions [13] and transferred into WT mice. To be certain that protection mediated by C7 CD4 T cells is antigen specific, we generated a strain of M. tuberculosis in which a key TCR contact residue in the ESAT-6 epitope (E12) was mutated to alanine to abolish C7 recognition ( Figure 1A ). M. tuberculosis ESAT6-E12A was fully virulent, but was not affected by Th1-differentiated C7 cells, whereas wild type M. tuberculosis titers were reduced by approximately 50 fold ( Figure 1B and C) .
Next, we transferred ten million C7.WT or C7.IFNc deficient Th1 effector cells into WT mice that were subsequently aerosolinfected with Mtb and, twenty-one days later, the number of bacteria in the lungs was determined. Surprisingly, both C7.WT and C7.IFNc deficient cells provided similar levels of protection compared to animals that did not receive cells (Figure 2A ), indicating that IFNc production by adoptively transferred effector CD4 T cells is not required for protection when these cells are present at the time of infection. To examine whether IFNcindependent restriction of Mtb growth is a specific property of C7 transgenic T cell populations or a general property of Mtb specific T cells, we generated bone marrow chimeric mice in which wild type recipient C57BL/6 mice received a 50:50 mixture of bone marrow from Rag2-deficient and IFNc-deficient donors. In these chimeric mice, all T cells are IFNc-deficient, while Rag2-independent innate immune cells, such as NK cells, macrophages, monocytes and DCs are capable of producing IFNc. Bone marrow chimeric mice with IFNc-deficient T cells were similarly resistant to Mtb infection as mice receiving wild type T cells, supporting our conclusion that T cells can mediate protection without producing IFNg and that our results with transgenic T cells extend to native T cell populations ( Figure S1 ). We also examined whether naïve C7 cells could limit M. tuberculosis growth and whether this effect is independent of IFN-c. 10,000 naïve C7 cells significantly reduced M. tuberculosis bacterial load in the lung at 22 days ( Figure S1B ). IFNc deficient T cells also significantly reduced bacterial loads and there was no significant difference in the ability of wild type and IFNc deficient naïve cells to control M. tuberculosis growth ( Figure  S1B ).
Because IFNc is essential for effective immune control of Mtb, we speculated that IFNc deficient C7 cells might recruit IFNcexpressing host-derived cells (e.g. Natural Killer cells or endogenous CD4 or CD8 T cells) to sites of mycobacterial infection. In this way, host-derived IFNc might activate the expression of mycobactericidal factors. To address this hypothesis, we tested that 
Author Summary
Mycobacterium tuberculosis (Mtb) is an inhaled pathogen that primarily infects the lungs and causes the disease, tuberculosis. Recent WHO statistics show that more than 2 billion people are infected with Mtb, of these over 1 million people die every year. Researchers over the last several decades have tried to determine how our immune system fights Mtb infection. It is known that CD4 T cells, and the pro-inflammatory cytokine, IFNc, are required to control Mtb infection in humans and in mice. Based on these observations, it is commonly assumed that vaccines that maximize IFNc-producing Mtb-specific CD4 T cell numbers will be the most effective. For the first time, we tested this idea directly and our results led us to the unexpected finding that Mtb specific CD4 T cells do not require IFNc in order to protect mice from Mtb infection. Our results challenge the model that optimization of IFNcproducing CD4 T cells will optimize vaccine induced protection against M. tuberculosis. ability of adoptively transferred T cells to provide protection in mice lacking IFNc. Remarkably, both WT and IFNc-deficient C7 effector cells protected hosts lacking IFNc, although in this setting IFNc-deficient T cells were slightly but significantly less effective than WT C7 cells at limiting in vivo growth of Mtb. Nevertheless, compared to IFNc deficient mice that did not receive T cells, animals that received C7 IFNc deficient effectors had ,30 fold reduction in bacterial numbers in the lungs at day 21 following infection ( Figure 2B ). This result demonstrates that CD4 T cells have a highly effective effector pathway to control Mtb that is completely independent of IFNc.
During murine infection with Mtb, IFNc signaling induces NOS2 (inducible nitric oxide synthase), leading to the generation of nitric oxide (NO) which can kill mycobacteria [14] . To determine whether adoptively transferred C7 T cells mediate protection by inducing NOS2, we transferred C7 T cells into NOS2 deficient mice. WT C7 effectors were effective at protecting both NOS2 and PHOX deficient mice from infection, resulting in ,70 fold reduction in bacterial numbers in NOS2 or PHOX deficient C7-recipients compared to deficient mice that did not receive cells ( Figure 2C ) and Figure S2 . NOS2 induction is a major IFNc-dependent effector mechanism controlling defense against Mtb in mice, yet our results show that C7 T cells that produce IFNc are similarly protective in WT and NOS2-deficient hosts. Taken together, our results demonstrate the existence of an IFNc/ NOS2-independent mechanism of CD4 T cell mediated killing of Mtb that is operative at the early time points examined in this study.
Optimal control of M. tuberculosis growth can be independent of IFNc and TNF production by effector T cells Tumor necrosis factor (TNF) is another critical regulator of host defense that is secreted by Th1 CD4 T cells. The precise contribution of TNF to defense against Mtb infection is difficult to define since it has been implicated in lymphocyte recruitment, cell survival, and mycobacterial killing [3, 15, 16] . We next determined whether TNF deficient C7 cells could protect WT and TNF deficient mice from Mtb infection. The protection provided to recipient mice either by WT or TNF deficient C7 effector cells was comparable, demonstrating that TNF production by effector CD4 T cells is not required for protection against Mtb infection ( Figure 3A) . Similarly, TNF-deficient naïve C7 T cells provided the same level of protection as adoptively transferred wild-type C7 T cells ( Figure S1B ). Experiments using TNF deficient hosts showed that TNF deficient effectors reduced the number of bacteria by ,100 fold, compared to TNF deficient hosts that did not receive C7 effectors ( Figure 3B ). Although adoptively transferred TNF-deficient C7 effectors were slightly less effective than WT C7 effectors at providing protection in TNF deficient recipients, TNF-deficient C7 effector T cells still provided a high degree of protection in TNF deficient recipients, an effect that could also be observed macroscopically in infected lungs, with TNF deficient hosts having large lesions that are diminished in size in TNF deficient recipients of either WT or TNF deficient C7 effectors ( Figure 3C ).
It is possible that the protection provided by IFNc or TNF deficient C7 T cells might result from partial functional redundancy of these two cytokines. To test this idea, we generated C7 cells lacking both IFNc and TNF (C7. Figure S1B ). These results indicate that CD4 T cells, independent of both TNF and IFNc, provide roughly 10 to 15 fold inhibition of Mtb growth.
We considered the possibility that the gamma/TNF independent pathway of antimycobacterial immunity demonstrated above might depend on cell dose. In the above experiments, the high cell dose (10 million) might allow a minor pathway of antimycobacterial immunity to substitute for the gamma/TNF pathway. To address this question, we repeated our experiments with one million transferred cells, which in our prior experience still provided substantial killing of M. tuberculosis [13] . One million transferred WT C7 cells reduced the bacterial load in the lungs of infected mice by 160 fold compared with animals that received no cells ( Figure 3E ). One million IFNc deficient T cells retained substantial antimycobacterial effect, reducing bacterial loads by 36 fold compared to control animals ( Figure 3E ). Similarly, TNF deficient cells reduced bacterial loads by 74 fold. IFNc/TNF deficient cells were somewhat impaired in their antimycobacterial effect, but still reduced bacterial loads by 23 fold. Taken together, these experiments indicate both IFNc/TNF dependent and independent pathways of T cell mediated protection. The majority of protection conferred by the C7 cells is, however, IFNc independent, even at lower T cell doses.
Cytolysis via perforin and FAS are not required to control of M. tuberculosis infection
MHC-class II restricted cytolytic activity has been observed following Mtb infection and has been suggested to contribute to protective immunity [17, 18] . Since Mtb-specific cells deficient in both IFNc and TNF protected mice from infection, we investigated whether ESAT-6-specific CD4 T cell cytolytic activity contributed to in vivo protection. To determine whether C7 effector cells killed target cells presenting the ESAT-6 epitope in vivo, we transferred C7 WT or C7.IFNc.TNF double deficient CD4 T cells into mice and 3 days later injected these mice with CFSE-labeled, ESAT-6-coated target cells. We detected approximately 60-80% specific lysis of ESAT-6-coated target cells in recipients of either C7.WT or C7.IFNc.TNF double deficient effectors ( Figure 4A and B) . This high degree of cytolysis is similar to what was observed for endogenous populations of Mtb-specific CD4 T cells [17] . To determine the contribution of perforin in CD4 T cell-mediated protection against Mtb infection, we compared bacterial numbers in infected mice that did not receive cells to recipients of C7.WT or C7.perforin deficient, Th1-differentiated effector T cells. Figure 4C -demonstrates that perforin deficient T cells were able to restrict Mtb growth to the same extent as wild type T cells, indicating that perforinmediated cytolytic activity does not contribute to the T cellmediated control of mycobacterial infection we observe.
Mice lacking functional FAS or FASL are more susceptible to Mtb infection than WT animals [19] . To determine if FAS mediated signaling contributes to C7 T cell-mediated protection of mice from Mtb infection, we modified our adoptive transfer protocol since C7.WT cells transferred before infection into FAS deficient hosts were undetectable 21 days following infection (data not shown). Instead of transferring C7 cells prior to infection, C7 effector cells were transferred 7 days following infection and bacterial numbers were measured 7 days later. The shorter experiment led to a similar recovery of C7 cells in WT and FAS deficient hosts (data not shown). Figure 4D ( shows that deficiency in FAS signaling did not alter the ability of C7 effectors to protect against Mtb infection, since comparable bacterial numbers were cultured from WT and FAS deficient recipient mice. Elimination of both perforin and FAS had only a minor, albeit statistically significant effect on protection mediated by C7 cells Figure 4E ). In addition, Perforin deficient C7 cells were also as capable as C7.WT cells at protecting iNOS deficient mice from infection ( Figure S3 ). Taken together, these results demonstrate that early control of mycobacterial infection does not require CD4 T cells to kill Mtb-infected target cells by FAS or perforin-mediated cytolytic activity.
Optimal protection to M. tuberculosis requires a Th-1 lineage population, yet is independent of T-bet
Because no single Th1-associated effector pathway was essential for T cell mediated protection against Mtb infection (i.e., IFNc, TNF, perforin, and FAS), we asked whether protection is a general property of helper T cells regardless of their effector phenotype. To address this question, naïve C7 cells were differentiated into Th2 and Th17 cells and transferred into WT hosts prior to Mtb infection. C7 TCR tg mice were crossed to the T-bet deficient background to prevent in vivo conversion of Th2 and Th17 populations into cells with a Th1 profile (AMG and EGP unpublished data, and [20] ). Twenty-one days following infection, lungs were harvested from infected animals and the frequencies and phenotypes of transferred populations were determined ( Figure 5 ). While frequencies of Th1-skewed cells (on either a WT or T-bet deficient background), and Th17-skewed cells were similar, compared to these populations, the frequencies of Th2-skewed cells were reduced. Of note, adoptively transferred T cells, including Th2-skewed cells, inhibited the priming of host-derived endogenous populations of ESAT-6 specific cells, indicating that adoptively transferred cells were participating in the immune response ( Figure S4 ). Since the degree of inhibition is directly correlated with the number of transferred effector cells (data not shown and [21] ), we concluded from this result that recipient mice, at least at the time of endogenous T cell priming, harbored similar frequencies of adoptively transferred cells.
The cytokine and transcription factor profiles of adoptively transferred T cells correspond to the expected phenotypes based on the in vitro culturing conditions [22] . As expected, while WT Th1 cell populations contained IFNc producing cells, all T-bet deficient cells examined (i.e., Th1, Th2, and Th17 skewed cells) did not produce detectable levels of IFNc ( Figure 5B ). Th2-differentiated T-bet deficient C7 T cells expressed IL4 and GATA3, while Th17-skewed C7 cells expressed IL17 and RORct ( Figure 5B and C) . Th1-skewed T-bet deficient C7 T cells also expressed IL17 and RORct, albeit in lower proportions. Figure 5D demonstrates that Th2-skewed cells marginally protected mice from infection, demonstrating that protection is not a general feature of all effector CD4 T cells. Th1-skewed, T-bet-deficient C7 T cells protected mice as well as Th1-skewed, WT C7 T cells, corroborating our finding that IFNc production by Mtb-specific CD4 T cells is unnecessary for early protection against Mtb infection. T-bet deficient C7 T cells differentiated under Th17 conditions provided protection, however [23] , we consistently observed better protection by Th1-differentaited, T-bet deficient C7 T cells, despite seemingly similar cytokine and transcription factor profiles between these two populations ( Figure 5B and C) . Taken together, our results suggest that protection against Mtb infection is optimal when effector T cells are differentiated under Th1 conditions, however in a T-bet independent fashion.
IFNc and TNF are central to host defense against Mtb infection in both mice and humans. However, because these cytokines have pleiotropic roles in T cell differentiation, cell trafficking, and macrophage activation, and are produced by a wide variety of immune cells, the exact mechanism(s) by which they confer protection has not been clearly defined. One predominant model is that Th1 effector T cells, which are known to produce both IFNc and TNF, are the important in vivo sources of these cytokines and thereby activate macrophage mycobactericidal effector functions. However, there have been occasional reports in which protection against Mtb infection did not correlate with production of IFNc by CD4 effector cells [5, 8, 9, 10] , suggesting either that other cellular sources of these cytokines are important, or that IFNc independent mechanisms of protection may exist. The data presented here provide strong support for a mycobactericidal effector function of CD4 T cells that is independent of both IFNc and TNF. These results may indicate that the central role of these cytokines is to prime CD4 differentiation to the Th1 phenotype, after which other effector functions kill Mtb. When cells with a Th1 phenotype are supplied, IFNc becomes dispensable. Our findings do not dispute the evidence that IFNc plays an essential role in immunity to Mtb, rather they show that antigen experienced effector cells have mechanisms to control infection that do not rely on IFNc mediated signals [24, 25] . When these cells are supplied at the time of infection, T cells can be highly effective at limiting Mtb growth. Our findings suggest that vaccination strategies that seek to maximize IFNc producing CD4 T cells may miss an important effector mechanism of Th1 CD4 T cells that we demonstrate is highly effective at controlling Mtb growth in vivo. Further exploitation of this new pathway therefore holds promise for the design of vaccines to control Mtb infection.
Materials and Methods
Mice
This study was carried out in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. The protocol was approved by the MSKCC Institutional Animal Care and Use Committee. No non-human primates were used in this research. C57BL/6J mice, iNOS ko (#002609), and FAS deficient mice (#000482) were purchased from Jackson Laboratory. C7.IFNc ko, C7.TNF ko, C7.IFNc.TNF dl ko, C7.perforin ko, C7.T-bet ko, IFNc ko, TNF ko, and gp91 phox ko mice were maintained at the animal facility in the memorial Sloan-Kettering 
Generation of effector T cells
4610
6 purified C7 TCR tg CD4+T cells were cultured with 12610 6 irradiated T cell-depleted splenocytes and 5 mg/ml of ESAT-6 1-20 peptide. At days 2 and 3 of culture, the cells were split 1:2, and 50 U/ml IL-2 was added (R&D Systems). For Th1 cultures, 10 ng/ml IL-12, and 5 mg/ml of neutralizing anti-IL-4 antibody (R&D Systems) were added at day 0 of culture. For Th17 cultures, 10 mg/ml of anti-IFNc and anti-IL-4 and 5 ng/ml of hTGF-b, 20 ng/ml of IL6 and 20 ng/ml of IL-23 were added at day 0 of culture. For Th2 cultures, 10 mg/ml of anti-IFNc. and 20 ng/ml of IL4 were added to cultures.
Aerosol infections with M. tuberculosis and generation of M. tuberculosis Erdman strains
Mice were infected at 8-10-wks of age with M. tuberculosis Erdman and plated as described [13] M. tuberculosis Erdman strain, Desat6::hyg (SSM6), has a deletion in the gene encoding ESAT-6 [26] . This strain was complemented with PMH406, which integrates at the chromosomal attB site, which uses the mop promoter to drive expression of CFP-10 and ESAT-6 [27] . Either wild type ESAT-6 or mutated ESAT-6 in which amino acid number 12 was changed from glutamic acid to alanine (E12A) were used to generate Desat6::hyg attB::pMH406 or Desat6::hyg attB::pMH406-ESAT6(E12A) .
Statistical analysis
For comparison of means between two groups we performed the unpaired Student's t test in GraphPad Prism software. For experiments that involved more than three groups (e.g Figures 3E, 5A, 5D) , we compared the groups using a one way ANOVA with a Bonferroni's multiple comparison test. 10,000 naïve C7 cells of the indicated genotype were transferred on the day before infection and bacterial loads in the lungs of infected mice were determined 22 days after infection. * p,0.05; ** p,0.001 calculated by one way ANOVA. (PDF) Figure S2 C7 effector cells protect PHOX ko mice from Mtb infection. Bacterial numbers of either WT or PHOX ko mice that either did not receive cells or received WT Th1-skewed C7 effector cells. The data shows lung bacterial numbers 21 days post infection. Differences were compared using unpaired Student's t test. (PDF) Figure S3 C7.perforin ko effector cells protect iNOS ko mice from Mtb infection. Bacterial numbers 21 days post infection in iNOS ko mice that either did not receive effector cells or received either perforin ko or WT Th1 skewed effector cells. Differences were tested using unpaired Student's t test. (PDF) Figure S4 C7 effector T cells prevent activation of host-derived ESAT-6 specific cells. C7 CD4 T cells from the indicated genetic backgrounds were activated in vitro under Th1, Th2, or Th17-skewing conditions. These cells were transferred into B6 mice that were subsequently infected with Mtb. Twenty-one days later, the frequencies of host-derived ESAT-6 specific cells in the lungs were determined by intracellular cytokine staining following ESAT-6 stimulation. (A) Flow cytometry plots gated on host-derived CD4 T cells, demonstrates that host-derived ESAT-6 specific cells (IFNg + TNF +) are undetectable in animals that received Th1, Th2, and Th17-skewed cells. (B) Analysis from 5-10 mice per experimental group. (PDF)
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